1. Alda M,
Turecki G, Grof P, Cavazzoni P, Duffy A, Grof E, Lafrenière R, Ahrens B, Berghöfer A, Müller-Oerlinghausen B, Dvoráková M,
Libigerová E, Vojtechovský M, Zvolský P, Nilsson A, Prochazka H, Licht RW, Rasmussen
NA, Schou M, Vestergaard P, Holzinger A,
Schumann C, Thau K, Rouleau GA.: Association and linkage studies of CRH and PENK genes in
bipolar disorder: a collaborative IGSLi study. Am J Med Genet 96:178-181, 2000.
2. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM,
Vohl M-C, Nemesh J, Lane CR, Schaffner FC,
Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L & Lander ES.: The common PPARgamma Pro12Ala polymorphism is
associated with decreased risk of type 2 diabetes. Nat Genet 26:76-80, 2000.
3.
Anderson TJ, Elstein E, Haber H, Charbonneau
F: Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel
blockade on flow-mediated vasodilation in patients with coronary disease. J Am Coll
Cardiol 35:60-66, 2000.
4. Arthus M-F, Lonergan M, Crumley MJ, Naumova AK, Morin D,
De Marco LA, Kaplan BS, . Robertson GL, Sasaki S, Morgan K, Bichet DG and Fujiwara TM:
Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic
diabetes insipidus. J Am Soc Nephr 11:1044-1054, 2000.
5.
Bétard C, Rasquin-Weber A, Brewer C, Drouin E, Clark S, Verner A,
Darmond-Zwaig C, Fortin J, Mercier J, Chagnon P, Fujiwara TM, K. Morgan, Richter A, Hudson
TJ and Mitchell GA: Localization of a recessive gene for North American Indian childhood
cirrhosis to chromosome region 16q22 - and identification of a shared haplotype. Am J Hum
Genet 67:222-228, 2000.
6. Blumen SC, Korczyn AD, Lavoie H, Medynski S, Chapman J,
Asherov A, Nisipeanu P, Carasso RL, Bouchard JP, Tome FMS, Rouleau GA, Brais B.:
Oculopharyngeal Muscular Dystrophy among Bukhara Jews is due to an old Founder Effect
producing the (GCG)9 expansion in the PABP2 gene. Neurology
55:12676-1270, 2000.
7.
Calado A, Tome FM, Brais B, Rouleau GA, Kuhn U, Wahle E, Carmo-Fonseca M.: Nuclear
inclusions in the oculopharyngeal muscular dystrophy consist of Poly(A) binding protein 2
aggregates which sequester poly(A) RNA. Hum Mol Genet 9:2321-2328, 2000.
8.
Cantarovich M, Quantz M, Elstein E, Ergina P, Magnan C, de Varennes B: Neoral dose
monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving
anti-thymocyte globulin induction. Transplant Proc 32:446-448, 2000.
9.
Chang H, Hall GA, Geerts WH, Greenwood CMT, McLeod RS, Sher GD: Allogeneic red blood cell
transfusion in an independent risk factor for the development of postoperative bacterial
infections. Vox Sanguinis 78:13-18, 2000.
10.
Chango A, Droesch S, Pfister M, Boisson F, Barbé F, Quillion D, Frémont S, Rosenblatt DS
and Nicolas JP: The effect of 677C?T and 1298A?C mutations on plasma homocysteine and
5,10-methylenetetrahydrofolate reductase activity in healthy volunteers. Br J Nutr
83:593-596, 2000.
11.
Chango A, Emery-Fillon N, Potier de Courcy G, Lambert D, Pfister M, Rosenblatt DS.,
Nicolas J-P.: A polymorphism (80G-->A) in the reduced folate carrier gene and its
associations with folate status and homocysteinemia. Molec Genet Metabol 70:310-315, 2000.
12.
Chappuis PO, Kapusta L, Bégin LR, Wong N, Brunet J-S, Narod SA, Slingerland J and Foulkes
WD: Germline BRCA1/2 mutations and p27Kip1 protein levels independently predict outcome
after breast cancer. J Clin Oncol 18: 4045-4052, 2000.
13.
Ciani F, Donati MA,Tulli G, Poggtti GM, Pasquini E, Rosenblatt DS, and Zammarchi E: Lethal late onset cblB methylmalonic aciduria. J
Critical Care Med 28:2119-2121, 2000.
14.
Denghien I, Joober R, Rouleau GA, Néri C.: Polyglutamine tracts in schizophrenia: gaining
new insigts. Molecular Psychiatry 5:236-7, 2000.
15. Dion F, Mes-Masson A-M, Seymour RJ, Provencher D and Tonin
PN: Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous
epithelial ovarian cancers. Oncogene 19: 1466-1472, 2000.
16.
Duffy A, Turecki G, Grof P, Cavazzoni P, Grof E, Lafrenière R, Ahrens B, Berghöfer A, Müller-Oerlinghausen B, Dvoráková M,
Libigerová E, Vojtechovský M, Zvolský P, Nilsson A, Prochazka H, Licht RW, Rasmussen
NA, Schou M, Vestergaard P, Holzinger A,
Schumann C, Thau K, Rouleau GA, Alda M.: Association and linkage studies of candidate
genes involved in GABAergic neurotransmission in lithium responsive bipolar disorder. J
Psychiatry Neurosci 25:353-358, 2000.
17. Engert JC, Bérubé P, Mercier J, Doré C, Lepage P, Ge B,
Bouchard J-P, Mathieu J, Melançon SB, Schalling
M, Lander ES, Morgan K, Hudson TJ and Richter A: ARSACS, a spastic ataxia common in
northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat
Genet 24:120-125, 2000.
18.
Foulkes WD, Chappuis PO, Wong N, Brunet J-S, Vesprini D, Rozen F, Yuan ZQ, Pollak MN,
Kuperstein G, Narod SA and Bégin LR. Primary node negative breast cancer in BRCA1
mutation carriers has a poor outcome. Ann Oncol 11: 307-313, 2000.
19. Furakawa Y, Guttman M, Sparagana SP, Trugman J, Hyland K,
Wyatt P, Land AE, Rouleau GA, Shimadzu M, Kish SJ.: Dopa-responsive dystonia due to a
large deletion in the GTP cyclohydrozylase I gene. Ann Neuro 47:517-520, 2000.
20. Gaspar C, Jannatipour M, Dion P, Laganiere J, Sequeiros J,
Brais B, Rouleau GA.: CAG tract of MJD-1 may be prone to frameshifts causing polyalanine
accumulation. Hum Mol Genet 9:1957-66, 2000.
21. Gaudet D, Hudson TJ & Laberge C.: From community
genetics to community genomics: The Quebec
Experience. Community Genetics 3:134-140, 2000.
22. Gaudet D, Arseneault S, Pérusse L, Vohl MC, St-Pierre J,
Bergeron J, Després J-P, Dewar K, Daly MJ, Hudson TJ & Rioux JD.: Glycerol as a
correlate of impaired glucose tolerance: dissection of a complex system using a simple
genetic trait. Am J Hum Genet 66:1558-1568, 2000.
23.
Giguère Y, Dodin S, Blanchet C, Morgan K and Rousseau
F: The association between heel ultrasound and hormone replacement therapy is modulated by
a two-locus vitamin D and estrogen receptor genotype. J Bone Mineral Res 15:1076-1084,
2000.
24.
Greenwood CMT and Morgan K: The impact of transmission ratio distortion on allele sharing
in affected sibling pairs. Am J Hum Genet
66:2001-2004, 2000.
25.
Greenwood CMT, Fujiwara TM, Boothroyd LJ, Miller MA, Frappier D, Fanning EA, Schurr E and Morgan K: Linkage
of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian
family. Am J Hum Genet 67:405-416, 2000.
26.
Hamel N, Black MJ, Ghadirian P and Foulkes WD: No association between p53 codon 72
polymorphism and risk of squamous cell carcinoma of the head and neck. Br J Cancer
82:757-759, 2000.
27.
Hamel N, Karimi S, Hébert M-N, Brunet J-S, Gilfix B, Ghadirian P, Black MJ, Narod SA,
Foulkes WD.: Increased risk of head and neck cancer in asspciation with GSTT1 nullizygosity for individuals with low exposure to
tobacco. Int J Cancer. 87:452-454, 2000.
28.
Hayes S, Turecki G, Brisebois K, Lopes-Cendes I, Gaspar C, Riess O, Ranum LPW, Pulst S-M,
Rouleau GA.: CAG repeat length in RAI1 is associated with age at onset variability in
spinocerebellar ataxia type 2 (SCA2). Hum Mol Genet 9:1753-1758, 2000.
29.
Joober R, Benkelfat C, Lal S, Bloom D, Labelle A, Lalonde P, Turecki G, Rozen R, Rouleau
GA.: Association between the
methylenetetrahydrofolate reductase 677C?T missense mutation and schizophrenia. Molecular
Psychiatry 5:323-326, 2000.
30. Joober R, Toulouse A, Benkelfat C, Lal S, Bloom D, Labelle
A, Lalonde P, Turecki G, Rouleau GA.: DRD3 and DAT1 genes in schizophrenia: an association
study. J
Psychiatr Res 34:285-291, 2000.
31. Khoris J, Moulard B, Briolotti V, Hayer M, Durieux A,
Clavelou P, Malafosse A, Rouleau GA, Camu W.: Coexistence of dominant and recessive
familial amyotrophic lateral sclerosis with the D90A Cu,Zn superoxide dismutase mutation
within the same country. Eur J Neurol
7:207-211, 2000.
32. Kibar Z, Dubé M-P, Powel J, McCuaig, Zonana J, Hayflick
SJ, Hovnanian A, Radhakrishna U, Antonarakis SE, Benohanian A, Sheeran AD, Stephan ML,
Gosselin R, Kelsell DP, Christianson AL, Fraser FC, Der Kaloustian VM, Rouleau GA.:
Clouston hidrotic ectodermal dysplasia (HED): genetic homogeneity, presence of a founder
effect in the French-Canadian population and fine genetic mapping. Eur J Hum Genet 8:372-380, 2000.
33. Knight SJL, Lese CM, Precht KS, Kuc J, Ning Y, Lucas S,
Regan R, Brenan M, Nicod A, Lawrie NM, Cardy DLN, Nguyen H, Hudson TJ, Riethman HC,
Ledbetter DH & Flint J.: An optimized set of human telomere clones for studying
telomere integrity and architecture. Am J Hum Genet 67:320-332, 2000.
34. Kuperstein G, Foulkes WD, Ghadirian P, Hakimi J and Narod
SA. A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1
and BRCA2 genes. Clin Genet 57:213-220, 2000.
35.
Lamartine J, Laoudj D, Blanchet-Bardon C, Kibar Z, Soularue P, Ridoux V, Dubertret L,
Rouleau GA, Waksman G.: Refined localization of the gene for Clouston Syndrome (Hidrotic
Ectodermal Dysplasia) in a large French family. Br J Dermatology 142:248-242, 2000.
36. Lamartine J, Pitaval A, Soularue P, Lanneluc I, Lemaitre
G, Kibar Z, Rouleau GA, Waksman G.: A 1.5-Mb
physical map of the hidrotic ectodermal dysplasia (Clouston syndrome) gene region on human
chromosome 13q11. Genomics 67:232-236, 2000.
37. Lamartine J, Essenfelder GM, Kibar Z, Lanneluc I, Callouet
E, Laoudj D, Lemaître G, Hand C, Hayflick SJ , Zonana J, Antonorakis S, Kelsell DP,
Christianson AL, Pitaval A, Der Kaloustian V, Fraser C, Blanchet-Bardon C, Rouleau GA,
Waksman G.: Mutations in GJB6 cause hidrotic ectodermal dysplasia. Nat Genet
26:142-144, 2000.
38. Lee P & Hudson TJ.: La puce à ADN en médecine et en
science. Méd/Sci
16:43-49, 2000.
39. Legoix P, Der Sarkissian H, Cazes L, Giraud S, Sor F,
Rouleau GA, Lenoir G, Thomas G, Zucman-Rossi J.: Molecular characterization of germline
NF2 gene rearrangements. Genomics 65:62-66, 2000.
40. Lindblad-Toh K, Tanenbaum DM, Daly MJ, Winchester E, Liu
W-O, Villapakkam A, Stanton SE, Larsson C, Hudson TJ, Johnson BE, Lander ES & Meyerson
M.: Loss-of-heterozygosity analysis of small-cell lung carcinomas using single nucleotide
polymorphism arrays. Nat Biotech
18:1001-1005, 2000.
41. Lindblad-Toh K, Winchester D, Daly MJ, Wang DG, Hirschhorn
NJ, Laviolette J-P, Ardlie K, Reich DE, Robinson E, Sklar P, Shah N, Thomas D, Fan J-B,
Gingeras T, Warrington J, Patil N, Hudson TJ & Lander ES.: Large-scale discovery and
genotyping of single nucleotide polymorphisms in the mouse. Nat Genet 24:381-386, 2000.
42. Liu G, Ghadirian P, Vesprini, D, Hamel N, Paradis A-J, Lal
G, Gallinger S, Narod SA and Foulkes WD. Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk
of pancreatic cancer. Br J Cancer 82:1646-9, 2000.
43.
Lopes-Cendes I, Scheffer IE, Berkovic SF, Rousseau M, Andermann E, Rouleau GA.: A new
locus for idiopathic generalized epilepsy maps to chromosome 2. Am J Hum Genet 66:698-701,
2000.
44. Manderson EN, Mes-Masson A-M, Provencher D, Tonin PN.:
Mutations in a 10 bp-polyadenine repeat of TGF-ß-RII in RER+ human epithelial ovarian
cancer. Clin Genet. 57:151-153, 2000.
45. Marquet S, Lepage P, Hudson TJ, Musser JM & Schurr E.:
Complete nucleotide sequence and genomic structure of the human NRAMP1 gene region on
Chromosome region 2q35. Mammalian Genome 11:755-762, 2000.
46.
Metcalfe K, Liede A, Hoodfar E, Scott A, Foulkes WD and Narod SA: An evaluation of needs
among female BRCA1 and BRCA2 mutation carriers undergoing genetic counselling. J Med Genet
37:866-874, 2000.
47. Minassian BA, Ianzano L, Meloche M, Andermann E, Rouleau
GA, Delgado-Escueda AV, Scherer SW.: Mutation spectrum and predicted function of laforin
in Lafora's progressive myoclonus epilepsy. Neurology
55:341-346, 2000.
48.
Narod SA, Brunet S-B, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D,
Lerman C, Pasini B, de los Rios P, Weber B, Lynch H, the Hereditary Breast Cancer Clinical
Study Group. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation
carriers: a case-control study. Lancet 356:1876-1881, 2000.
49.
Nimgaonkar VL, Fujiwara TM, Dutta M, Wood J, Gentry K, Maendel S, Morgan K and Eaton J:
Low prevalence of psychoses among the Hutterites, an isolated religious community. Amer J Psychiatry. 157:1065-1070, 2000.
50. O'Neil WM, Gilfix BM, Markoglu N, Di
Girolamo A, Tsoukas CM and Wainer IW.: Genotype and phenotype of cytochrome P450 2D6 in
HIV-positive patients and patients with AIDS. Eur J Clin
Pharmacology. 56:231-240,
2000.
51.
Pei Y, Greenwood CMT, Chery A and Wu G: Racial
differences in cardiovascular disease burden and mortality in patients on dialysis. Kidney
International 58:1293-1299, 2000.
52. Provencher DM, LounisH, Champoux L, Tetrault M, Manderson
E, Wang JC, Eydoux P, Savoie R, Tonin PN and Mes-Masson A-M: Characterization of four
novel epithelial ovarian cancer cell lines. In Vitro Cell Dev Biol Animal 36:357-361,
2000.
53.
Rahman N, Arbour L, Houlston R, Bonaïti-Pellié C, Abidi F, Tranchemontagne J, Ford D,
Narod SA, Pritchard-Jones K, Foulkes WD, Schwartz C and Stratton MR. Penetrance of
mutations in the familial Wilms tumor gene, FWT1. J Natl Cancer Inst 92:650-652, 2000.
54. Rapley E, Barfoot R, Bonaiti-Pellie C, Chompret A, Foulkes
W, Perusinghe N, Reeve A, Royer-Pokora B, Schumacher V, Shelling A, Skeen J, de Tourreil
S, Weirich A, Pritchard-Jones K, Stratton MR, Rahman N. Evidence for susceptibility genes
to familial Wilms tumour in addition to WT1, FWT1and FWT2.Br J Cancer 83:177-83, 2000.
55. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS,
Griffiths AM, Green T, Brettin TS, Stone V,
Bull SB, Bitton A, Williams CN, Greenberg GR, Cohen Z, Lander ES, Hudson TJ & Siminovitch KA.: Genome-wide search in Canadian
families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum
Genet 66:1863-1870, 2000.
56. Rosenblatt DS: The evolution of medicine --- a
geneticist's point of view. Clin Invest Med 23:59-61, 2000.
57. Ross BM, Eder K, Moszczynska A, Mamalias N, Lamarche J,
Ang L, Pandolfo M, Rouleau G, Kirchgessner M, Kish SJ.: Abnormal activity of membrane
phospholipid synthetic enzymes in the brain of patients with Friedreich's ataxia and
spinocerebellar atrophy type-1. Movement Disorders 15:294-300,
2000.
58. Shanmugam V, Dion P, Rochefort D, Laganiere J, Brais B,
Rouleau GA. PABP2 polyalanine tract expansion causes intranuclear inclusions in
oculopharyngeal muscular dystrophy. Ann Neuro 48:798-802, 2000.
59.
Sibani S, Christensen B, O'Ferrall E, Saadi I, Hiou-Tim F, Rosenblatt DS and Rozen R:
Characterization of six novel mutations in the methylenetetrahydrofolate reductase (MTHFR)
gene in patients with homocystinuria. Hum Mutation.15:280-287, 2000.
60.
Singh R, Eeles RA, Durocher F, Simard J, Edwards S, Badzioch M, Kote-Jarai Z, Teare D,
Ford D, Dearnley D, Ardern-Jones A, Murkin A, Dowe A, Shearer R, Kelly J, The CRC/BPG UK
Familial Prostate Cancer Study Collaborators, Labrie F, Easton D, Narod SA, Tonin PN and
Foulkes WD: High risk genes predisposing to
prostate cancer development- do they exist? Prostate Cancer and Prostatic Diseases
3:241-247, 2000.
61.
Turecki G, Alda M, Grof P, Cavazzoni P, Duffy A, Grof E, Lafrenière R, Joober R, Ahrens
B, Berghöfer A, Müller-Oerlinghausen B, Dvoráková M, Libigerová E, Vojtechovský M,
Zvolský P, Nilsson A, Prochazka H, Licht RW, Rasmussen NA, Schou M, Vestergaard P,
Holzinger A, Schumann C, Thau K, Rouleau GA.: Polyglutamine coding genes in bipolar
disorder: investigation of selected candidate loci. J Aff Disor 58:63-68, 2000.
62. Turecki G, Brière R, Dewar K, Lesage A, Séguin M, Chawky
N, Vanier C, Alda M, Joober R, Benkelfat C, Rouleau GA.: Dr. Turecki and colleagues reply.
Am J Psychiatry 1710-1711, 2000.
63. Vohl, M-C, Lepage P, Gaudet D, Brewer CG, Bétard C,
Perron P, Houde G, Cellier C, Faith JM, Després
J-P, Morgan K and Hudson TJ: Molecular scanning of the human PPARa gene: association of
the L162V mutation with hyperapobetalipoproteinemia. J Lipid Res 41:945-952, 2000.
64. Wang J-C, Mes-Masson A-M, Tonin PN, Provencher D and
Eydoux P: Trisomy of chromosome 10 in two cases of ovarian epithelial carcinoma. Cancer
Genet Cytogenet 118:65-68, 2000.
65. Watkins D, Matiaszuk N and Rosenblatt DS: Complementation
studies in the cblA class of inborn errors of cobalamin metabolism: Evidence for
interallelic complementation and for a new complementation class (cblH). J Med Genet
37:510-513, 2000.
66. Xu
JF and International Consortium for Prostate Cancer Genetics (ICPCG). Combined Analysis of
Hereditary Prostate Cancer Linkage to 1q24-25: Results from 772 Hereditary Prostate Cancer
Families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet
66: 945-957, 2000 (WDF is a member of the ICPCG writing committee for this paper).
67. Yuan ZQ, Chong GL, Thompson-May S, Trifiro M, Khandjian
EW, Rousseau F, Yandell D, McNamara E, Gordon PH and Foulkes WD. Analysis of the hMLH1 and
hMSH2 genes in three Quebec families with Hereditary Non-Polyposis Colorectal Cancer. Ann
Roy Coll Phys Surg Canada 33:287-291, 2000.
1.
Chapman NH, Crumley J, Fujiwara TM, Morgan K and Thompson EA: Population history affects
the expected number of ancestral chromosome segments. (Poster at the Annual Meeting of the
American Society of Human Genetics, 3-7 October 2000, Philadelphia) Am J Hum Genet 67(4-Suppl):234, 2000.
2. Chagnon P, Bétard C, Rasquin-Weber A, Brewer C,
Drouin E, Clark S, Verner A, Darmond-Zwaig C, Fortin J, Mercier J, Morgan K, Fujiwara TM,
Richter A, Hudson TJ and Mitchell GA: Localisation du gène responsable de NAIC sur le
chromosome 16q22: une forme de cholestase progressive familiale fréquente chez les
enfants Ojibway-Cree. Oral presentation by Pierre Chagnon at Génétique humaine au
Québec: Qui fait quoi? Troisièmes Journées de Génétiques, Le Réseau de médecine
génétique appliquée du FRSQ p. 16, 2000.
3.
Engert JC, Bérube P, Mercier J, Doré C, Lepage P, Ge B, Bouchard JP, Mathieu J,
Melançon SB, Schalling M, Lander ES, Morgan K, Hudson TJ and Richter A: ARSACS, a spastic
ataxia common in the founder population of northeastern Quebec, is caused by mutations in
a novel gene encoding a gigantic exon with an 11.5 kb open reading frame. Journées
Scientifiques 2000, Centre de recherche du Centre hospitalier de l'Université de
Montréal, 7-8 February 2000, Montréal, Programme p. 17, 2000.
4. Engert JC, Vohl M-C, Lepage P, Doré C, Brewer C, Frappier
D, Verner A, Platko J, Rioux J, Gaudet D, Morgan K and Hudson TJ: A genome-wide scan for
CHD susceptibility in the Saguenay-Lac-Saint-Jean region of Quebec. Am J Hum Genet 67(4-Suppl):303, 2000.
5.
Frosk P, Greenberg CR, Hitchon C, Canvin JMG, Weiler T, Sudha T, Morgan K, Fujiwara TM,
Wrogemann K: Low serum creatine kinase can be seen in LGMD2H individuals with co-existing
rheumatoid arthritis. Am J Hum Genet 67(4-Suppl):283, 2000.
6. Ghadirian P, Narod S, Brunel JS, Perret C, Foulkes WD,
Tonin PN: Risk of other cancers among French Canadians family members of BRCA1 and BRCA2
gene carriers. Am J Hum Genet 67(4-Suppl):499, 2000.
7.
Gilfix BM, Hsiung EMW, Elstein E.: Levels of aminothiols in heart transplant patients.
Transplantation 69 (8): S237, 2000.
8. Gilfix BM, Hsiung EMW, Elstein E.: Determination of the
levels of aminothiols in plasma and urine following reduction with
tris(carboxyethyl)phosphine. American Association of Clinical Chemistry. 52nd Annual
Meeting & Clin Lab Expo, July 23-27,
2000.
9.
Goobie SL, Popovic M, Morrison MJ, Ellis L, Ginzberg H, Bétard C, Brewer C, Hudson TJ, Fujiwara TM, K. Morgan, P. Durie, and J.M.
Rommens: Mapping of the major locus for Shwachman-Diamond syndrome at 7p12-q11. Human
Genome Meeting Programme & Abstract Book, p. 76, 2000.
10. Greenwood CMT and Morgan K: Model-free linkage analysis
incorporating disease epidemiology. Genet
Epidemio 19:251-252, 2000.
11.
Greenwood CMT, Fujiwara TM, Schurr E and K. Morgan: Tuberculosis susceptibility is linked
to chromosome 2q at NRAMP1 in a large aboriginal Canadian family. Human Genome Meeting 000
Programme & Abstract Book, p. 51, 2000.
12. Greenwood CMT, Loredo-Osti JC, Roslin NM, Crumley MJ,
Brewer CG, Fujiwara TM and Morgan K: The
potential uses of too much ancestral information. Genetic Analysis Workshop 12(1):136-140,
2000.
13.
Hamel N, Ghadirian P, Paradis A-J, Robidoux A, Potvin C, Cantin J, Tonin PN, Chappius,
Foulkes WD. 2000. Prevalence of founder BRCA1 and BRCA2 mutations in French Canadian women
with breast cancer unselected for age or family history. Génétique
humaine au Québec: Qui Fait Quoi?, Troisièmes Journées Génétiques, Réseau de
médecine génétique appliquée du FRSQ.
14. Hamel N, Ghadirian P, Paradis A-J, Robidoux A, Potvin C,
Cantin J, Kuperstien G, Tonin PN, Deschênes J, Chappius PO, Foulkes WD. 2000 Prevalence
of founder BRCA1 and BRCA2 mutations in French Canadian women with breast cancer
unselected for age or family history. Am J Hum Genet 67(4-Suppl):398, 2000.
15.
Landry K, Seyrantepe V, Chang Y, Ausseil J, Morzol N, Rosenblatt DS and Pshezhetsky A:
Proteomic maps of lysosomal membranes as a tool to study the molecular basis of lysosomal
transport diseases. Am J Hum Genet 67 (4-Suppl):386, 2000.
16. Laprise C, Murphy J, Brewer C, Morgan K, Fortin J, Bétard
C, Verner A, Faith J, Gagné D, Bégin P and Hudson TJ: A genome-wide search for asthma
susceptibility loci in a French-Canadian founder population. Am J Respiratory Critical Care Med 161(3):A601,
2000.
17.
Manderson E, Mes-Masson A-M, Novak J, Lee P, Provencher D, Hudson T, Tonin P. 2000.
Analyse de l'expression différentielle de gènes localisés sur le chromosome 3p dans les
adénocarcinomes ovariens par la technologies des Abiopuces
A D N. ACFAS.
18. Manderson E, Mes-Masson A-M, Novak J, Lee P, Provencher D,
Hudson T, Tonin PN. 2000. Analysis of expression of genes which map to chromosome 3p in
epithelial ovarian cancer using DNA microarrays. Society of Obstetricians &
Gynecologists of Canada, ACM.
19.
Nadeau JH, Ernest SE, Christensen B, Hosack A and Rosenblatt DS: Genetic controls of
homocysteine metabolism in mice: interacting pathways and expression profiles. Am J Hum
Genet 67 (4-Suppl):344, 2000.
20. Nikkel SM, Mhanni A, Dilling L, Seargeant L, Stobart K,
Rosenblatt DS, Gorlin JB, Korson MS, Greenberg CR, and Prasad C.: Methylmalonic aciduria,
hyperhomocysteinemia, and/or neurologic abnormalities in 3 infants born to mothers with
asymptomatic B12 deficiency. Genet in Med 2:29, 2000.
21.
Pavia C, Oriola J, Kasprzak L, Villabona C, Nolet S, Foulkes WD, Rivera-Fillat F: Familial
Medullary Thyroid Carcinoma with the V804M Mutation in the Proto-Oncogene RET: Findings in
One Family. Hormone Research 53 (S2):158, 2000.
22. Presneau, N, Mes-Masson A-M, Jaroslav N, Lee P, Provencher
D, Hudson T, Tonin PN. Etude de l'expression differentialle de genes localises sur le
chromosome 17 dans les adenocarcinomes ovariens par la technologie des puces à AND.2000.
Génétique humaine au Québec: Qui Fait Quoi?, Troisièmes Journées Génétiques,
Réseau de médecine génétique appliquée du FRSQ
23.
Presneau N, Mes-Masson A-M, Novak J, Lee P, Provencher D, Hudson T, Tonin PN. 2000. Study of differential expression
of genes located on chromosome 17 in epithelial ovarian cancer by DNA chips. Society of
Obstetricians & Gynecologists of Canada, ACM.
24. Rosenblatt DS, Watkins D, and Matiaszuk N.:Vitamin
B12-responsive methylmalonic aciduria due to a new inborn error of adenosylcobalamin
synthesis, cblH. Genet in Med 2:73, 2000.
25.
Rosenblatt DS, Guy M, Kim CD, Murray A, Hilton JF, Gravel RA, Wilson A, Shane B, Ru M: The
molecular basis of cblG disease-four novel mutations in methionine synthase. Pediatr Res
47 (4):244A, 2000.
26. Rosenblatt DS, Guy M, Kim CD, Murray A, Hilton FJ, Gravel
RA, Wilson A, Shane B and Ru M: The molecular basis of cblG disease-novel mutations in
methionine synthase causing hyperhomocysteinemia. Qui fait
quoi? Troisièmes Journées de Génétiques, Le Réseau de médecine génétique
appliquée du FRSQ 11, 2000.
27. Rosenblatt DS: What
do rare inborn errors of metabolism teach us about activation of human methionine
synthase? Am Chem Soc Dec 2000.
28.
Rosenblatt DS, Ru M, Ge B and Hudson TJ: P1173L is a recurrent mutation in the methionine
synthase gene causing cblG hyperhomocysteinemia. Am J Hum Genet 67 (4-Suppl):277, 2000.
29. Rousseau
F, Lévesque S, Dombrowski C and Morgan K: Génétique moléculaire et des populations du
syndrome de l'X-fragile. Qui fait quoi? Troisièmes Journées de Génétiques, Le Réseau
de médecine génétique appliquée du FRSQ Montreal, 4, 2000.
30.
Tejada-Berges T, Champoux L, Hudson T, Tonin PN, Golub T, Provencher D, Mes-Masson A-M.
2000. Expression of
heat shock proteins in human epithelial ovarian cancer cell lines. Society of
Obstetricians & Gynecologists of Canada, ACM
31. Tejada-Berges
T, Tetrault M, Champoux L, Hudson T, Tonin PN, Golub T, Provencher D, Mes-Masson A-M.
2000. Evaluating
differential expression of protein phosphatases in human epithelial ovarian cancer.
Society of Obstetricians & Gynecologists of Canada, ACM
32.
Tonin PN, Foulkes WD, Provencher D, Mes-Masson A-M, Narod SA, Ghadirian P. 2000.
Contribution of founder BRCA1 and BRCA2 mutations in site-specific hereditary breast
cancer (HBC) and families of French Canadian descent. Qui fait
quoi? Troisièmes Journées de Génétiques, Le Réseau de médecine génétique
appliquée du FRSQ, 2000.
33. Vohl M-C, Lepage P, Gaudet D, Brewer CG, Bétard G, Perron
P, Houde G, Cellier C, Faith JM, Després
J-P, Morgan K and Hudson TJ: Association de la mutation L162V du gène PPAR-alpha à de
l'hyperapo-bêtalipoprotéinémie. Qui fait
quoi? Troisièmes Journées de Génétiques, Le Réseau de médecine génétique
appliquée du FRSQ 7, 2000.
34.
X.-L. Wang, A. Klitorinos, Gilfix BM.: Frequency of a HR2 haplotype in individuals
carrying the Factor V Leiden mutation.
Qui
fait quoi? Troisièmes Journées de Génétiques, Le Réseau de médecine génétique
appliquée du FRSQ 3:12, 2000.
